TY - JOUR
T1 - Development and implementation of an electrolyte replacement protocol in the outpatient oncology infusion centers of a large academic healthcare system
AU - Ajewole, Veronica B.
AU - Solomon, Jenna M.
AU - Schneider, Amy M.
AU - Heyne, Kirk E.
N1 - Funding Information:
The authors appreciate Oyinkansola Akindele and Collins Enwerem (Doctor of Pharmacy Interns) for contribution with data review for this study. The authors appreciate David Putney, PharmD, MPH, BCPS (AQ-Cardiology) for his assistance with statistical analysis for this study. The author(s) received no financial support for the research, authorship, and/or publication of this article.
Publisher Copyright:
© The Author(s) 2020.
Copyright:
Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - Background: Patients receiving chemotherapy frequently experience electrolyte imbalances. Electrolyte replacement is, therefore, a necessity as patients may experience life-threatening symptoms. Study objective: The objective of this study was to evaluate the occurrence of low serum potassium and magnesium, and identify the rate of replacement for patients with low serum potassium and magnesium levels. Based on our findings, we developed and implemented a nursing-driven electrolyte replacement protocol. Methods: Preimplementation phase – A retrospective review for serum potassium and magnesium values obtained during infusion clinic visit between 1 August and 31 October 2016 was conducted. Implementation phase – A nursing-driven electrolyte replacement protocol with medication order “smart-set” and order selection intelligence within EPIC Beacon was developed and implemented in May 2017. Postimplementation phase – The postimplementation phase data were collected from 1 August to 30 November 2017 using a similar approach as the preimplementation phase. Results: Preimplementation phase – During the preimplementation phase of the study, a total of 1495 serum potassium levels and 1193 serum magnesium levels were obtained. Among the 152 patients who needed potassium replacement, 34% (n = 52) were replaced and among the 118 serum magnesium levels that needed replacement, 30% (n = 35) were replaced. Postimplementation phase – 3979 serum potassium and 2707 magnesium levels were obtained. Among the 170 patients who needed potassium replacement, 75% (n = 127) were replaced. Among the 142 patients who needed magnesium replacement, 73% (n = 104) were replaced. Conclusion: A 121% increase in potassium replacement and a 143% increase in magnesium replacement were identified after implementing this protocol.
AB - Background: Patients receiving chemotherapy frequently experience electrolyte imbalances. Electrolyte replacement is, therefore, a necessity as patients may experience life-threatening symptoms. Study objective: The objective of this study was to evaluate the occurrence of low serum potassium and magnesium, and identify the rate of replacement for patients with low serum potassium and magnesium levels. Based on our findings, we developed and implemented a nursing-driven electrolyte replacement protocol. Methods: Preimplementation phase – A retrospective review for serum potassium and magnesium values obtained during infusion clinic visit between 1 August and 31 October 2016 was conducted. Implementation phase – A nursing-driven electrolyte replacement protocol with medication order “smart-set” and order selection intelligence within EPIC Beacon was developed and implemented in May 2017. Postimplementation phase – The postimplementation phase data were collected from 1 August to 30 November 2017 using a similar approach as the preimplementation phase. Results: Preimplementation phase – During the preimplementation phase of the study, a total of 1495 serum potassium levels and 1193 serum magnesium levels were obtained. Among the 152 patients who needed potassium replacement, 34% (n = 52) were replaced and among the 118 serum magnesium levels that needed replacement, 30% (n = 35) were replaced. Postimplementation phase – 3979 serum potassium and 2707 magnesium levels were obtained. Among the 170 patients who needed potassium replacement, 75% (n = 127) were replaced. Among the 142 patients who needed magnesium replacement, 73% (n = 104) were replaced. Conclusion: A 121% increase in potassium replacement and a 143% increase in magnesium replacement were identified after implementing this protocol.
KW - Electrolyte replacement protocol in EPIC BEACON
KW - electrolyte replacement protocol in outpatient infusion center
KW - hypokalemia in chemotherapy patients
KW - hypomagnesemia in chemotherapy patients
KW - outpatient oncology infusion centers
UR - http://www.scopus.com/inward/record.url?scp=85081640547&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081640547&partnerID=8YFLogxK
U2 - 10.1177/1078155220907671
DO - 10.1177/1078155220907671
M3 - Article
C2 - 32131681
AN - SCOPUS:85081640547
SN - 1078-1552
VL - 26
SP - 1871
EP - 1877
JO - Journal of Oncology Pharmacy Practice
JF - Journal of Oncology Pharmacy Practice
IS - 8
ER -